Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia. Mohty M, Kharfan-Dabaja MA. N Engl J Med 2025;392:2180-2181.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mohty M, Kharfan-Dabaja MA. Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia. N Engl J Med 2025;392:2180-2181.
PMID: 40466081